Risk factor | Univariate log-rank analysis (p) | Multivariate analysis | |
---|---|---|---|
p | HR (95.0% CI) | ||
Age | 0.563 | Â | Â |
Sex (median as cut-off) | 0.180 | Â | Â |
Smoking history | 0.326 | Â | Â |
Duration (median as cut-off) | 0.297 | Â | Â |
Surgical approach (PLT versus VATS) | 0.004 | 0.017 | 0.407 (0.195–0.851) |
Surgical scope (sublobar resection versus lobectomy and combined lobectomy) | 0.933 | Â | Â |
Tumour location (peripheral type versus central type) | 0.942 | Â | Â |
Pathological type (pure versus mixed) | 0.471 | Â | Â |
T stage | 0.000 | Â | Â |
N stage | 0.002 | 0.034 | 1.689 (1.042–2.740) |
M stage | 0.000 | 0.001 | 6.712 (2.229–20.211) |
Tumour size (median as cut-off) | 0.004 | 0.278 | 1.637 (0.672–3.983) |
TNM stage | 0.000 | Â | Â |
Complication (yes versus no) | 0.411 | Â | Â |
AT (all) | 0.586 | Â | Â |
AT (stage I) | 0.054 | Â | Â |
Neoadjuvant therapy | 0.037 | 0.416 | 0.605 (0.181–2.028) |